Daniel Hallak is an experienced process engineer with a strong background in bioprocessing and quality control. Currently serving as a Process Engineer III at CRB since December 2021, Daniel previously held roles at Eli Lilly and Company and Celgene, focusing on downstream manufacturing operations, deviation investigations, and microbiological responsibilities. Daniel's earlier experience includes substantial design and equipment support for large-scale bioprocesses, alongside research and development roles at Lehigh University. Daniel holds a Bachelor of Science in Chemical Engineering from Lehigh University, obtained in 2016.
This person is not in the org chart
This person is not in any teams
This person is not in any offices